Detection of Pathogenic Variants With Germline Genetic Testing in Patients With Prostate Cancer and Melanoma
This study compares pathogenic variant detection accuracy in cancer-disposition genes of prostate cancer and melanoma cohort biopsy samples using deep learning vs standard genetic analysis methods.
Source: JAMA - Category: General Medicine Source Type: research
More News: Cancer | Cancer & Oncology | General Medicine | Genetics | Learning | Melanoma | Prostate Cancer | Skin Cancer | Study | Universities & Medical Training